APRA Finalises Amendments to the Capital Treatment for Longevity Products

APRA Finalises Amendments to the Capital Treatment for Longevity Products

Regulation Tomorrow (Norton Rose Fulbright)
Regulation Tomorrow (Norton Rose Fulbright)Apr 1, 2026

Why It Matters

The changes give Australian insurers a path to capital efficiency while tightening prudential oversight, influencing product pricing and risk management in the longevity market.

Key Takeaways

  • APRA adopts advanced illiquidity premium for longevity products
  • 45% floor for AILP remains unchanged
  • New reporting template released, feedback due May 12
  • Effective date set for July 1, 2026
  • Governance and asset limits tightened for illiquid liabilities

Pulse Analysis

Longevity products—annuities and other contracts that pay out in later life—represent a growing segment of Australian insurers’ balance sheets. Because payouts are tied to uncertain mortality trends, regulators require insurers to hold capital against the illiquid liability risk. The Australian Prudential Regulation Authority (APRA) has been revisiting the capital framework since mid‑2025, seeking a model that rewards efficient asset‑liability matching while safeguarding policyholder protection. The latest response paper, issued on 31 March 2026, finalises a set of amendments that codify the advanced illiquidity premium (AILP) as an optional capital relief mechanism.

The AILP allows insurers to apply a risk‑adjusted discount to the capital charge for longevity liabilities, provided they meet stricter governance, reporting and asset‑composition standards. APRA retained the proposed 45 % floor on the premium, arguing that market conditions where credit spreads are ultra‑narrow are rare and do not justify a lower threshold. While some industry submissions urged more flexibility on asset limits, the regulator concluded that the current parameters strike the right balance between capital efficiency and prudential oversight. Clarifications, such as renaming the products ‘illiquid liabilities,’ aim to reduce regulatory ambiguity.

For insurers, the July 1 2026 implementation date signals a near‑term need to adjust internal models, update risk dashboards, and train actuarial teams on the new reporting template. Those that adopt the AILP could see modest capital relief, potentially translating into more competitive pricing for annuity offerings. Conversely, firms that opt out must continue holding higher capital buffers, which may affect profitability in a low‑interest‑rate environment. APRA’s invitation for feedback on the template by 12 May 2026 also offers a window for industry to shape the practical rollout, reinforcing a collaborative regulatory approach.

APRA finalises amendments to the capital treatment for longevity products

Comments

Want to join the conversation?

Loading comments...